Envisagenics Company
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
Investors
.png)
Total Funding:
27056626
Headquarters:
New York, New York, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Last Funding Type:
Series A
Investor Type:
info@envisagenics.com
Last Funding Date:
2023-05-11
Investors Number:
16
Founded Date:
2014-04-22
Industry:
Medical BioTech